학술논문
Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) follow-up of CheckMate 649.
Document Type
Article
Author
Shitara, Kohei; Moehler, Markus H.; Ajani, Jaffer A.; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan S.; Yamaguchi, Kensei; Cleary, James M.; Elimova, Elena; Bruges Maya, Ricardo Elias; Karamouzis, Michalis; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Tehfe, Mustapha; Feeney, Kynan; Wang, Rui; Nathani, Raheel; Janjigian, Yelena Y.
Source
Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p306-306, 185p
Subject
Language
ISSN
0732183X